DEC 30, 2021 3:00 AM PST

Integrative Oncology Prolongs Breast Cancer Survival

WRITTEN BY: Katie Kokolus

We often describe cancer according to where it originates, such as breast cancer, lung cancer, or pancreatic cancer.  This terminology can create a mindset that cancer, and its adverse effects, are isolated to a specific area.  However, cancer impacts the whole individual, not just one specific organ.  A growing body of evidence supports benefits to caring for all aspects of the person, including the mind, body, and spirit. 

Treating cancer is inevitably complex, and treatment management depends not only on specific properties of cancer but also characteristics of the individual patient, such as age or comorbidities.  Conventional medicine based on biomedical research drives cancer treatment decisions but, cancer patients are increasingly incorporating complementary approaches into their individualized treatment program. 

Combining conventional and complementary therapies to treat the whole patient compromises integrative oncology. Comprehensively, integrative oncology is defined as “a patient-centered, evidence-informed field of cancer care that utilizes mind-body practices, natural products, and/or lifestyle modifications from different traditions alongside conventional cancer treatments.” In addition to surgery, drugs, and other medical interventions, integrative oncology includes complementary treatments like patient support groups and massage therapy. While many such alternative approaches are generally accepted to benefit overall health, it is not standard for oncologists to make or follow up on such recommendations.  

Emerging research concentrates on the value of complementary therapies, but a lack of clinical studies has prevented standardized incorporation into medical practice. To address this, a new report in The Journal of Oncology investigated how institutional commitment to integrative oncology approaches affected breast cancer survivorship.  

The authors collected data from breast cancer patient claims and surveys completed by 103 oncologists.  From these sources, the researchers assessed the level of support for twelve complementary therapies offered at the institutions.  The complementary therapies considered included nutrition and exercise consultation, patient support groups, spiritual services, psycho-oncology counseling, massage therapy, meditation, yoga, acupuncture, music or art therapy, reiki or healing touch, and tai chi or qi gong.  The researchers also collected outcome data of almost 200 breast cancer patients treated at 103 US cancer treatment centers.  The patients all received conventional treatment such as chemotherapy, immunotherapy, targeted therapy, radiation, or surgery. 

The study ranked the institutions with low, low-mid, mid-high, or high levels of support for complementary therapies.  Notably, breast cancer patients treated at institutions ranked at low-mid, mid-high, or high levels of support were three times more likely to achieve five-year survival than those treated at low-ranking institutions. 

The authors discussed ways low-scoring institutions can increase support of alternative therapies and thus, possibly increase survival among their patients.  One suggestion encourages providing online resources and discussing complementary treatments during consultations.  The authors also suggest that offering access to some therapies on-site, free of cost, could increase compliance. 

Overall, the study concluded that breast cancer patients treated at hospitals committed to providing integrative oncology services exhibited longer survival than patients treated at hospitals that did not emphasize these diverse approaches.  Comprehensive, larger-scale studies to confirm these findings could help push these approaches into mainstream medical practice.

 

Sources: J Natl Cancer Inst Monogr, J Oncol

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
SEP 14, 2022
Health & Medicine
Researchers Suggest Updating Alcohol Warning Labels
SEP 14, 2022
Researchers Suggest Updating Alcohol Warning Labels
Current warning labels that appear on alcohol products in the US are outdated, vague, and not helpful to people who want ...
SEP 28, 2022
Drug Discovery & Development
Impact of In Vivo Controls on Therapeutic Drug Development
SEP 28, 2022
Impact of In Vivo Controls on Therapeutic Drug Development
The significance of antibody based in vivo studies   For both research and therapeutic purposes, antibodies ca ...
OCT 20, 2022
Cancer
Mast Cells Facilitate Metastasis in HR+ Breast Cancer
OCT 20, 2022
Mast Cells Facilitate Metastasis in HR+ Breast Cancer
The gut microbiome describes the microorganisms and viruses that live throughout the digestive system.  The gut mic ...
OCT 31, 2022
Cancer
Pumpkins: A Trick or a Treat for Cancer?
OCT 31, 2022
Pumpkins: A Trick or a Treat for Cancer?
Cancer is a disease that impacts the whole person, wreaking havoc on an individual’s emotional and physical well-b ...
OCT 25, 2022
Cancer
Study Identifies Patients at High Risk of Breast Cancer Metastasis
OCT 25, 2022
Study Identifies Patients at High Risk of Breast Cancer Metastasis
Central nervous system metastasis (mCNS) accounts for most brain and spinal cord tumors.  While recent advances hav ...
NOV 29, 2022
Drug Discovery & Development
Chemotherapy May Increase Disease Susceptibility for Two Generations
NOV 29, 2022
Chemotherapy May Increase Disease Susceptibility for Two Generations
A common chemotherapy drug may make future generations more susceptible to disease. The corresponding study was publishe ...
Loading Comments...